ReviewArteriosclerosis, thrombosis, and vascular biology2026
Enhancer Dynamics for Gene Regulation in the Cardiovascular System.
Review in Arteriosclerosis, thrombosis, and vascular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Enhancers are regulatory DNA sequences that increase the transcription of a target gene when bound by transcription factors. Decades of research endeavors have shed light on the crucial roles of enhancers in cardiovascular development and disease. Besides working as cis-regulatory elements, enhancers also play critical roles in transactivating mechanisms such as enhancer RNA transcription and transcriptional condensates. Technological advances, such as single-cell multiomics, CRISPR (clustered regularly interspaced short palindromic repeats)-based enhancer perturbation screens, and machine learning technologies, provide us with unprecedented opportunities to gain novel insights into the dynamic function of cardiovascular enhancers. In this brief review, we discuss cutting-edge techniques that are being or can be leveraged to fill knowledge gaps in studying cardiovascular enhancers. Like gene expression, enhancers display functional dynamics in concordance with specific cellular stress. We summarize the findings of inducible enhancer functions in the cardiovascular system. We also discuss several recent studies that are advancing our understanding of cardiovascular enhancer functions and are potentially paradigm-shifting. These insights have great potential to inform novel therapeutic strategies targeting enhancer-mediated gene dysregulation in cardiovascular disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.